Learn about

Problem

Century-old heparin market faces ongoing shortages and significant challenges that could impact global health.

Solution

ExCulture’s novel, animal-free alternative is uniquely positioned to address the challenges faced by the current heparin market.

News

Milestones – fundraising, competition successes, and more. Read all about recent updates in our news and blog section! 

Supported by

What drives us?

To become the global pioneers of mixed culture fermentation for the efficient and reliable production of complex novel biopharmaceuticals.

DSM Firmenich Kickstart Fund 

DSM Firmenich Kickstart Fund 

On Friday 12th April 2024 ExCulture was announced as winner of the 2024 DSM-Firmenich Kickstart Prize, securing €50,000 after pitching to and...

Bio Spring Conference

Bio Spring Conference

Looking back on a successful first experience of the BioEurope Spring Conference held in Barcelona for ExCulture.We had the opportunity to make many...

Get  in touch

Type of interest

14 + 7 =